Results 91 to 100 of about 18,663 (157)

Genome sequence data of Streptomyces sp. SS52, an endophytic strain for daidzein biosynthesis

open access: yesData in Brief, 2019
We report here the biosynthesis of daidzein in Streptomyces sp. SS52, its genome sequence and the analysis of its genome for finding putative genes involved in daidzein biosynthesis. The Streptomyces sp.
Huong Van Nguyen   +4 more
doaj  

Isolation and identification of an isoflavone reducing bacterium from feces from a pregnant horse.

open access: yesPLoS ONE, 2019
The aim of this research was to isolate bacteria capable of biotransforming daidzein from fresh feces from pregnant horses. A Hungate anaerobic roller tube was used for anaerobic culture. Single colonies were picked at random and incubated with daidzein.
Xie Jinglong   +4 more
doaj   +1 more source

NMR Study on the Inclusion Complexes of β-Cyclodextrin with Isoflavones

open access: yesMolecules, 2016
The structure of the inclusion complexes of β-cyclodextrin (β-CD) with daidzein and daidzin in D2O were investigated using NMR spectroscopy. For the β-CD and daidzein system, two types of 1:1 complexes were formed with the daidzein deeply inserted into ...
Rui Zhao   +3 more
doaj   +1 more source

Chemotactic response of the flavonoid daidzein and its effect on the composition of the rumen bacterial community [PDF]

open access: yes, 2014
Daidzein is one of common metabolites in plants and has chemotactic effect on soil bacteria that colonize the plants. There are several tests to assess bacterial chemotaxis, but none focused on rumen bacteria. Therefore, the aim of this study was to test
Galicia Jiménez, Mónica M.   +4 more
core   +1 more source

The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: A randomized, double-blind, crossover study [PDF]

open access: yes, 2011
Context: There is concern whether soy phytoestrogens may affect thyroid function. If true, soy phytoestrogens may be expected to have a greater impact in subjects with subclinical hypothyroidism.
Atkin, Stephen L.   +6 more
core   +1 more source

Trajna primjena fitoestrogena daidzeina poboljšava srednji arterijski tlak i vaskularnu funkciju u L-NAME štakora s povećanim krvnim tlakom. [PDF]

open access: yes, 2015
The ‘silent killer’, hypertension, leads to heart disease, stroke, kidney failure and premature death. The phytoestrogen daidzein has been associated with vaso-protective action similar to oestrogen, with minimal side effects.
Azad A. Ahanger   +5 more
core   +1 more source

Comparative study of effects daidzein contained in yam tuber Pachyrhizus erosus and pure daidzein: the dynamics of chemical compounds and its potential in myometrium

open access: yesJournal of Biological Researches, 2014
Daidzein compounds dynamic and the effect of yam tuber (Pachyrhizus erosus (L)) Urb on myometrium rats model of estrogenic were investigated. Twentyfour of 5 months-old female Sprague Dawley rats were randomly assigned to three groups as followed ...
Cicilia Novi Primiani   +3 more
doaj   +1 more source

Immuno-histomorphometric and -fluorescent characteristics of GH cells after treatment with genistein or daidzein in an animal model of andropause

open access: yesActa Veterinaria, 2014
Somatopause, the complex aspect of andropause, is recognizable by reduced growth hormone - GH/insulin-like growth factor 1 axis function in the ageing male. Soy isoflavones (usually genistein and daidzein), which are known for their beneficial effects in
Ajdžanović Vladimir   +6 more
doaj   +1 more source

Comparison of the toxicokinetics of daidzein and bisphenol A in pregnant and non-pregnant DA/Han rats [PDF]

open access: yes
Potentially adverse human and environmental effects due to hormone mimicry of environmental estrogens are a matter of current concern. Environmental estrogens belong to the socalled endocrine active compounds (EAC) and may alter signalling processes of ...
Degen, Gisela H., Selinski, Silvia
core  

A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials [PDF]

open access: yes, 2017
There is no treatment for the myelin loss in multiple sclerosis, ultimately resulting in the axonal degeneration that leads to the progressive phase of the disease.
Agresti, C.   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy